FREE SHIPPING ON ORDERS OVER $150

dihexa peptide therapy (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |

$20.22

Quantity
- +
Description

No randomization

dihexa peptide therapy (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |

PMID: 25900608

dihexa peptide therapy (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |

Unlike most peptides, MOTS-c originates in the mitochondria, the energy-producing centers of cells, and works by improving metabolic efficiency and stress resilience

dihexa peptide therapy (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |

Breastfeeding Is it safe to use Neurobion Forte RF Injection during breastfeeding

dihexa peptide therapy (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |

Injection Technique Subcutaneous injection technique is identical to insulin

dihexa peptide therapy (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |

A total of 14 HPLC fractions were collected, separated from solvent in vacuum, the residue of each fraction was suspended in H 2 O (10 mL), freeze-dried twice and, then, screened for the target compounds showing the pseudomolecular ions m/z 453 and 837, respectively, by means of UPLC-TOF MS using the following chromatographic conditions (0.3 mL/min, 40 C): starting with a mixture of H 2 O/MeOH (40/60, v/v), the MeOH content was kept constant for 1 min at 60%, increased to 90% within 8 min, increased to 95% within 10 min, increased to 100% within 1 min, kept constant for 1 min, decreased within 1 min to 60% MeOH, followed by re-equilibration for 1 min

dihexa peptide therapy (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |

You may also like

recommand products